Heart 2006;92:1017-1018
EDITORIAL
Darwin and the survival of the fittest in modern interventional cardiology
Department of Interventional Cardiology, The Royal Brompton Hospital, London, UK
Correspondence to:
Professor Carlo Di Mario
Department of Interventional Cardiology, The Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK; c.dimario{at}rbh.nthames.nhs.uk
The diabetic patient requires a full armamentarium of proven and developing treatments in order to minimise periprocedural risk as well as improve long term outcome
Abbreviations: DES, drug eluting stents; Gp, glycoprotein; MACE, major adverse cardiac events; MI, myocardial infarction; PCI, percutaneous coronary intervention; TLR, target lesion revascularisation
Keywords: diabetes mellitus; glycoprotein IIb/IIIa; percutaneous coronary intervention; drug-eluting stent
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
- Full Text
- Full Text (PDF)
-
All Versions of this Article:
hrt.2005.083923v1
92/8/1017 most recent - Submit a response
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
- Citation Map
Services
- Email this link to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Bookmark with
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
